Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cutar is a specialty pharmaceutical company primarily known for its dermatological products, specifically Cutar Emulsion. The company focuses on providing therapeutic solutions for chronic skin conditions such as psoriasis, eczema, and seborrheic dermatitis. Its flagship product, Cutar Emulsion, is a coal tar-based treatment designed to be used in the bath or applied directly to the skin to reduce inflammation and itching. Cutar operates as a subsidiary of Summers Laboratories, leveraging their expertise in dermatological formulations. The company's products are widely recognized in the clinical community for their efficacy in managing difficult-to-treat skin disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cutar.